Molecular characterization and antifungal susceptibility of Aspergillus spp. isolated from critically ill COVID-19 patients: Implications for suspected COVID-19-associated pulmonary aspergillosis (CAPA) in a Brazilian tertiary referral hospital
Medical Mycology · 2026
DOI: 10.1093/mmy/myag092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Mycology, 2026. Verfasst von Tiago Alexandre Cocio und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo (USP), Avenida Bandeirantes, 3900-Monte Alegre, Ribeirão Pret…. Hauptthemen laut MEDLINE: Antifungal Agents, Aspergillus, COVID-19, Pulmonary Aspergillosis. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Fundação de Amparo à Pesquisa do Estado de São Paulo, Marcia Regina von Zeska Kress.
Abstract (Originalsprache)
COVID-19-associated pulmonary aspergillosis (CAPA) is a severe complication in critically ill patients, but species identification and antifungal resistance data from middle-income countries remain limited. We analyzed 17 Aspergillus isolates from respiratory specimens of 15 critically ill patients with COVID-19 in São Paulo State, Brazil, during 2020–2021. Patients were retrospectively classified according to ECMM/ISHAM criteria as probable CAPA (n = 5), possible CAPA (n = 7), or non-CAPA (n = 3). Complementary reassessment using the 2024 FUNDICU definitions classified patients as probable invasive pulmonary aspergillosis (IPA; n = 3), probable tracheobronchial aspergillosis (TBA; n = 1), or as not meeting these definitions (n = 9); two were ineligible due to classical EORTC/MSGERC host factors (n = 2). Species identification was performed by benA sequencing and MALDI-TOF MS. Susceptibility to amphotericin B (AMB), itraconazole (ITZ), voriconazole, and posaconazole (PCZ) was determined according to CLSI M38-A2, and cyp51A and its promoter were analyzed in A. fumigatus. The predominant species were A. fumigatus (n = 7) and A. flavus (n = 5), followed by A. tamarii (n = 2), A. parasiticus, A. terreus, and A. welwitschiae (n = 1 each). All A. fumigatus isolates exhibited non-wild-type phenotypes (NWT) against PCZ, with some also showing reduced susceptibility to ITZ and AMB. Silent cyp51A mutations occurred in three A. fumigatus isolates, while several section Flavi isolates displayed multiazole NWT. These findings highlight diagnostic limitations and emerging azole resistance, supporting susceptibility testing and surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo (USP), Avenida Bandeirantes, 3900-Monte Alegre, Ribeirão Preto, SP 14049-900, Brazil.
- Laboratory of Medical Investigation in Mycology (LIM53), Institute of Tropical Medicine, Faculty of Medicine, Department of Dermatology, University of São Paulo (USP), Avenida Dr. Enéas de Carvalho Aguiar, 470-Cerqueira…
- Laboratory of Medical Investigation in Immunology (LIM 48), Hospital das Clínicas, Faculty of Medicine, University of São Paulo (USP), Avenida Dr. Enéas de Carvalho Aguiar, 255- Cerqueira César, São Paulo, SP 05403-000,…
- Department of Clinical Analyses, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Avenida do Café, s/n- Monte Alegre, Ribeirão Preto, SP 14040-903, Brazil.
- School of Medicine, Federal University of Mato Grosso do Sul (UFMS), Avenida Costa e Silva, s/n-Bairro Universitário, Campo Grande, MS 79070-900, Brazil.
- School of Medicine, São Paulo State University (UNESP), Graduate Program of Tropical Diseases, Distrito de Rubião Júnior, s/n, Botucatu, SP 18618-687, Brazil.
ORCID-Profile: Tiago Alexandre Cocio, Gilda Maria Barbaro Del Negro, Marcia de Souza Carvalho Melhem, Tânia Sueli de Andrade, Marcello Mihailenko Chaves Magri, Gil Benard
Förderung
- Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Marcia Regina von Zeska Kress
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- FCT
Zitieren
APA
Cocio, T. A., Coelho, V. C., Tonani, L., Costa-Leite, I. G., Kress, M. R. V. Z., Del Negro, G. M. B., Melhem, M. S. C., Soares, C., Lima, N., de Andrade, T. S., Magri, M. M. C., Benard, G., Martinez, R., & Bollela, V. R. (2026). Molecular characterization and antifungal susceptibility of Aspergillus spp. isolated from critically ill COVID-19 patients: Implications for suspected COVID-19-associated pulmonary aspergillosis (CAPA) in a Brazilian tertiary referral hospital. Medical Mycology. https://doi.org/10.1093/mmy/myag092
Vancouver
Cocio TA, Coelho VC, Tonani L, Costa-Leite IG, Kress MRVZ, Del Negro GMB, et al. Molecular characterization and antifungal susceptibility of Aspergillus spp. isolated from critically ill COVID-19 patients: Implications for suspected COVID-19-associated pulmonary aspergillosis (CAPA) in a Brazilian tertiary referral hospital. Medical Mycology. 2026. doi:10.1093/mmy/myag092
BibTeX
@article{Cocio2026,
author = {Cocio, Tiago Alexandre and Coelho, Vivian Caso and Tonani, Ludmilla and Costa-Leite, Ingrid Gonçalves and Kress, Marcia Regina von Zeska and Del Negro, Gilda Maria Barbaro and Melhem, Marcia de Souza Carvalho and Soares, Célia and Lima, Nelson and de Andrade, Tânia Sueli and Magri, Marcello Mihailenko Chaves and Benard, Gil and Martinez, Roberto and Bollela, Valdes Roberto},
title = {Molecular characterization and antifungal susceptibility of Aspergillus spp. isolated from critically ill COVID-19 patients: Implications for suspected COVID-19-associated pulmonary aspergillosis (CAPA) in a Brazilian tertiary referral hospital},
journal = {Medical Mycology},
year = {2026},
doi = {10.1093/mmy/myag092}
}
EUVIMED